Objectives:
- Outline the basic principles of radiopharmaceutical theranostics for cancer therapy.
- Examine clinical trials from recent FDA approved theranostics agents.
- Discuss emerging use of dosimetry and imaging for patient selection and management
- Summarize developing UWCCC Theranostics DOT and clinical trials workflows
Zoom info:
Join from a PC, Mac, iPad, iPhone or Android device: Please click this URL to join. https://uwmadison.zoom.us/s/96001260645?pwd=OE5vcnZQZWtXbDNjN2J0U21rOHV6UT09 / Passcode: Grand
Or One tap mobile: +13126266799,,96001260645# US (Chicago) +16469313860,,96001260645# US
Or join by phone: Dial(for higher quality, dial a number based on your current location): US: +1 312 626 6799 or +1 646 931 3860 or +1 929 205 6099 or +1 301 715 8592 or +1 305 224 1968 or +1 309 205 3325 or +1 669 444 9171 Webinar ID: 960 0126 0645
International numbers available: https://uwmadison.zoom.us/u/adzH0Y19HO
Or an H.323/SIP room system: H.323: 162.255.37.11 (US West) or 162.255.36.11 (US East) / Webinar ID: 960 0126 0645 / Passcode: 645334
SIP: [email protected] / Passcode: 645334
- 1.00 AAPA Category 1 CME
- 1.00 ACPE Contact Hours - Pharmacist
- 1.00 ACPE Contact Hours - Pharmacist Technician
- 1.00 AMA PRA Category 1 Credit™
- 1.00 ANCC Contact Hours
- 1.00 University of Wisconsin–Madison Continuing Education Hours
- 1.00 Approved for AMA PRA Category 1 Credit™